Petri Bio

Petri Bio

Next-generation of therapeutics from gut microbes.

Print
Security Type
SAFE
Categories
Other
Min Investment
$100
Location
Los Angeles, CA
Offering Date
July 29, 2020
Expected Close Date
October 27, 2020
Target Raise
$50.00K-$1.07M

Company Description

Petri Bio is searching the gut microbiome for novel therapies for diseases that are tough to treat. Why gut microbes? Because we know they can influence a diverse array of health outcomes, we just don’t know how. But we do know they make millions of unstudied chemical compounds that interact with the body. Petri Bio believes the medicines of the future are among these compounds, waiting to be found.

Key Deal Facts

We develop therapeutics inspired by the data collected by animal and microbial genome projects.

Positioned to mine 32+ terabytes of genomic data for future drug precursors.

Founded by 2 PhD scientists (3 patents and 14 publications). 2nd-time founder (YCS17).

Patent-pending treatment for COVID-19 under evaluation by a pharma company for sponsorship.

Early pipeline of candidates help treat IBD, which affects 1.6M people and $15B market

Drug precursor for the treatment of NAFLD/NASH (“fatty liver disease”), $7B growing market.

Use of Proceeds

Research and reagents purchasing, Team salary, Lab renting, Wefunder Fees.

Research and product development, Lab Renting, Team and Hiring a Part-Time Research Assistant, Patent Filing and Regulatory Consulting, Wefunder Fees.

Research and product development, Lab Renting, Team and Hiring a Full-Time Scientist, Pre-Clinical Trial Studies, Patent Filing and Regulatory Consulting, Wefunder Fees.

Management Team / Advisory Board Bios

Shu Li
Co-Founder
Ph.D. with 8 publications and 3 patents. Y Combinator alum.


Joseph Schinaman
Co-Founder
Ph.D. with 14 years of research experience and 6 top tier publications, 1 patent. LA Biostart alum.
Amount Raised : $111,189
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A SAFE is an agreement between you—the investor—and the company in which the company promises to give you a future equity stake based on the amount you invested. It also involves some kind of a triggering event that must take place in order for you to get your future equity stake. Be careful as you may only get equity if a particular event is triggered.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments